SCHEMBL26868790

SCHEMBL26868790

Cc1cnn2c(N)cc([C@H](C)C3CCCC3)nc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNA2 P20248 10/20 0.34
▸ CDK2 P24941 10/20 0.34
▸ CCNA1 P78396 10/20 0.34
▸ CHEK1 O14757 9/20 0.34
▸ CCNT1 O60563 2/20 0.34
▸ CDK1 P06493 2/20 0.34
▸ CDK4 P11802 2/20 0.34
▸ CCND1 P24385 2/20 0.34
▸ CCNE1 P24864 2/20 0.34
▸ CDK7 P50613 2/20 0.34
▸ CDK9 P50750 2/20 0.34
▸ CCNH P51946 2/20 0.34
▸ CDK3 Q00526 2/20 0.34
▸ CDK6 Q00534 2/20 0.34
▸ CDK5 Q00535 2/20 0.34
▸ CDK5R1 Q15078 2/20 0.34
▸ KDM4E B2RXH2 5/20 0.34
▸ MEN1 O00255 4/20 0.34
▸ NPC1 O15118 4/20 0.34
▸ RAB9A P51151 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26868792 1.00 CCNA2 (0.34) CCNA2CDK2CCNA1CHEK1CCNT1
SCHEMBL26868788 1.00 CCNA2 (0.34) CCNA2CDK2CCNA1CHEK1CCNT1
SCHEMBL26868587 0.97 CDK2 (0.34) CCNA2CDK2CCNA1CHEK1CCNT1
SCHEMBL26868500 0.97 CDK2 (0.34) CCNA2CDK2CCNA1CHEK1CCNT1
SCHEMBL26868494 0.97 CDK2 (0.34) CCNA2CDK2CCNA1CHEK1CCNT1
SCHEMBL26868158 0.95 KDM4E (0.35) CCNA2CDK2CCNA1CHEK1CCNT1
SCHEMBL26868115 0.95 KDM4E (0.35) CCNA2CDK2CCNA1CHEK1CCNT1
SCHEMBL26868112 0.95 KDM4E (0.35) CCNA2CDK2CCNA1CHEK1CCNT1
SCHEMBL26868863 0.86 CDK2 (0.37) CCNA2CDK2CCNA1CHEK1CCNT1
SCHEMBL26868864 0.85 CDK2 (0.37) CCNA2CDK2CCNA1CHEK1CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4282868-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE-7-AMINE DERIVATIVE, AND COMPOSITIONS AND MEDICAL USE THEREOF Shanghai Haiyan Pharmaceutical Technology Co., Ltd (CN) 2023-11-29 — — EP disclosed
Send feedback